Weaning From Noninvasive Ventilation
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 197
- 试验地点
- 9
- 主要终点
- The comparison of total duration of NIV after randomization
研究概览
简要总结
Noninvasive ventilation (NIV) weaning strategies differ considerably from one another. These strategies have yet not been compared to each other. Therefore, the investigators planned to perform a prospective, randomized, pilot study involving hypercapnic acute respiratory failure patients ready to be weaned off from NIV. The investigators are going to compare the success rate of NIV weaning and the duration of NIV after randomization between 3 NIV weaning methods: gradual decrease in duration of NIV or level of ventilator support, and abrupt discontinuation of NIV.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients will be screened by the physician 24 hours (±6 hours) after initiation of NIV treatment if:
- •Age ≥18 years old
- •Hypercapnic ARF ( baseline pH<7.35, paCO2>45 mmHg, BORG>4)
- •Breathing frequency< 25 bpm under NIV
- •pH >7.35 under NIV
- •10% or more decrease from baseline PaCO2 under NIV
- •Kelly ≤ 2 under NIV (Alert. Follows simple/3 step complex commands)
- •PaO2 between 60 and 70 mmHg under NIV
- •No need for sedation
- •Systolic blood pressure 90-180 mmHg without vasopressors
- •Body temperature 36-38°C
- •Heart rate 50-120 bpm
- •The patient will be enrolled to the study and will be randomized to one of the NIV weaning protocols, if passes daily weaning criteria listed below after 1 hour of spontaneous breathing (with supplementary oxygen),
- •Respiratory rate 8-30 bpm
- •Systolic blood pressure 90-180 mmHg without vasopressors
- •Body temperature 36-38°C
- •Heart rate 50-120 bpm
- •Neurologic score of Kelly ≤2 (Alert. Follows simple/ 3-step complex commands),
- •SaO2 ≥88-92% with a FiO2≤40%.
- •Absence of severe dyspnea (BORG>4).
排除标准
- •Age <18 years old
- •NIV use at home for chronic respiratory failure
- •CPAP use for acute respiratory failure
- •NIV use as palliative treatment
- •Severe heart failure with cardiac index ≤ 2 L/min/m2
- •Severe hepatic failure with bilirubin ≥ 34.2µmol/L
- •Severe renal failure with creatinine ≥ 220 µmol/L
结局指标
主要结局
The comparison of total duration of NIV after randomization
时间窗: up to 10 days
The patients will be considered as 'weaning failure' if: * The participant will meet the NIV reinstitution or intubation criteria during the weaning phase or within the first 5 days of NIV discontinuation * Weaning from NIV was not possible If the failing patient stabilizes afterwards and passes the screening and weaning criteria, the patient will be weaned again with the same protocol. If the patient fails weaning trials 3 times, then the patient will not be re-considered for further enrollment.
次要结局
- NIV weaning success rates(10 days of NIV discontinuation)
- Rate of NIV re-institution(10 days of NIV discontinuation)
- Duration of ICU stay(up to 24 weeks)
- Rates of intubation(first 5 days of NIV discontinuation)
- In-hospital mortality(up to 24 weeks)
研究者
Aylin Ozsancak Ugurlu
MD
Baskent University